InVitro International EBIT

InVitro International (IVRO) currently reports a EBIT of $43K as of June 2026. That compares with $120K in the prior-year period — down 64.6% year over year. That is below the sector sector average of $2.5T. Use the charts on this page to explore InVitro International's EBIT history and peer comparisons.

InVitro International's EBIT decreased from $120K to $43K — a 64.6% year-over-year decrease (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

InVitro International's EBIT of $43K is lower than the its sector sector average of $2.5T. That is roughly 100.0% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

InVitro International reported $43K in EBIT as of June 2026. That compares with $120K in the prior-year period — down 64.6% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current EBIT of $43K, then check the historical chart for trend and the peer comparison chart for relative positioning. The sector average is $2.5T. From there, open related valuation or income-statement pages for InVitro International, and consider following IVRO for alerts when major investors trade the stock.